{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:50:52Z","timestamp":1762912252387,"version":"3.45.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":220,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K13708"],"award-info":[{"award-number":["21K13708"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.prdoa.2021.100105","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T04:30:15Z","timestamp":1628829015000},"page":"100105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preventive effect of a heparinoid-containing product on the application site reaction of the rotigotine transdermal patch in Parkinson\u2019s disease: A pilot randomized clinical trial (the SkinHeRo study)"],"prefix":"10.1016","volume":"5","author":[{"given":"Jinsoo","family":"Koh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Yorozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidefumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prdoa.2021.100105_b0005","first-page":"6621991","article-title":"Focus on depression in parkinson's disease: a delphi consensus of experts in psychiatry, neurology, and geriatrics","volume":"2021","author":"Ag\u00fcera-Ortiz","year":"2021","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.prdoa.2021.100105_b0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12883-016-0610-7","article-title":"Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease","volume":"16","author":"Hauser","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.prdoa.2021.100105_b0015","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/bph.12988","article-title":"Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors","volume":"172","author":"Wood","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prdoa.2021.100105_b0020","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archneur.64.5.676","article-title":"Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease","volume":"64","author":"Jankovic","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.prdoa.2021.100105_b0025","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/exd.13985","article-title":"A topical heparinoid-containing product improves epidermal permeability barrier homeostasis in mice","volume":"28","author":"Yao","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.prdoa.2021.100105_b0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2133.2003.04934.x","article-title":"Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis","volume":"148","author":"Furue","year":"2003","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.prdoa.2021.100105_b0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000513724","article-title":"Topical applications of a heparinoid-containing product attenuate glucocorticoid-induced alterations in epidermal permeability barrier in mice","volume":"34","author":"Wen","year":"2021","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.prdoa.2021.100105_b0040","first-page":"1047","article-title":"Efficacy of topical agents for symptomatic treatment of rotigotine patch-induced skin disorders","volume":"69","author":"Yasutaka","year":"2017","journal-title":"Brain Nerve."},{"key":"10.1016\/j.prdoa.2021.100105_b0045","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1346-8138.2002.tb00205.x","article-title":"The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases","volume":"29","author":"Higaki","year":"2002","journal-title":"J Dermatol."},{"key":"10.1016\/j.prdoa.2021.100105_b0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1477-7525-4-46","article-title":"Japanese version of the dermatology life quality index: validity and reliability in patients with acne","volume":"4","author":"Takahashi","year":"2006","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.prdoa.2021.100105_b0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0846.2007.00232.x","article-title":"Allergy patch test reading from photographic images: disagreement on ICDRG grading but agreement on simplified tripartite reading","volume":"13","author":"Ivens","year":"2007","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.prdoa.2021.100105_b0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13293-020-00308-5","article-title":"Sex differences in pharmacokinetics predict adverse drug reactions in women","volume":"11","author":"Zucker","year":"2020","journal-title":"Biol Sex Differ."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112521000177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112521000177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:46:23Z","timestamp":1762911983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112521000177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":12,"alternative-id":["S2590112521000177"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2021.100105","relation":{},"ISSN":["2590-1125"],"issn-type":[{"type":"print","value":"2590-1125"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive effect of a heparinoid-containing product on the application site reaction of the rotigotine transdermal patch in Parkinson\u2019s disease: A pilot randomized clinical trial (the SkinHeRo study)","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2021.100105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100105"}}